logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5145.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5145.produseast1
Proposed multidimensional framework for understanding Chagas disease healthcare barriers in the United States | Journal Article / Review | MSF Science Portal
Journal Article
|Review

Proposed multidimensional framework for understanding Chagas disease healthcare barriers in the United States

Forsyth C, Meymandi S, Moss I, Cone J, Cohen RM, Batista C
Download

Similar Content
Loading...
Loading...
Loading...
Abstract
BACKGROUND
Chagas disease (CD) affects over 300,000 people in the United States, but fewer than 1% have been diagnosed and less than 0.3% have received etiological treatment. This is a significant public health concern because untreated CD can produce fatal complications. What factors prevent people with CD from accessing diagnosis and treatment in a nation with one of the world's most advanced healthcare systems?

METHODOLOGY/PRINCIPAL FINDINGS
This analysis of barriers to diagnosis and treatment of CD in the US reflects the opinions of the authors more than a comprehensive discussion of all the available evidence. To enrich our description of barriers, we have conducted an exploratory literature review and cited the experience of the main US clinic providing treatment for CD. We list 34 barriers, which we group into four overlapping dimensions: systemic, comprising gaps in the public health system; structural, originating from political and economic inequalities; clinical, including toxicity of medications and diagnostic challenges; and psychosocial, encompassing fears and stigma.

CONCLUSIONS
We propose this multidimensional framework both to explain the persistently low numbers of people with CD who are tested and treated and as a potential basis for organizing a public health response, but we encourage others to improve on our approach or develop alternative frameworks. We further argue that expanding access to diagnosis and treatment of CD in the US means asserting the rights of vulnerable populations to obtain timely, quality healthcare.

Countries

United States of America

Subject Area

Chagas disease

Languages

English
DOI
10.1371/journal.pntd.0007447
Published Date
26 Sep 2019
PubMed ID
31557155
Journal
PLOS Neglected Tropical Diseases
Volume | Issue | Pages
Volume 13, Issue 9, Pages e0007447.
Dimensions Badge